KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $315.4 million.

  • Jazz Pharmaceuticals' Prepaid Assets fell 1094.65% to $315.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $315.4 million, marking a year-over-year decrease of 1094.65%. This contributed to the annual value of $261.5 million for FY2024, which is 1847.39% down from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Prepaid Assets is $315.4 million, which was down 1094.65% from $297.6 million recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Prepaid Assets registered a high of $354.2 million during Q3 2024, and its lowest value of $147.7 million during Q1 2021.
  • Over the past 5 years, Jazz Pharmaceuticals' median Prepaid Assets value was $261.5 million (recorded in 2024), while the average stood at $269.5 million.
  • In the last 5 years, Jazz Pharmaceuticals' Prepaid Assets surged by 7762.93% in 2021 and then tumbled by 1847.39% in 2024.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Prepaid Assets stood at $252.4 million in 2021, then grew by 5.86% to $267.2 million in 2022, then rose by 20.07% to $320.8 million in 2023, then fell by 18.47% to $261.5 million in 2024, then increased by 20.61% to $315.4 million in 2025.
  • Its last three reported values are $315.4 million in Q3 2025, $297.6 million for Q2 2025, and $259.8 million during Q1 2025.